Ge Long Hui A P P·2025-12-22 11:53Core Viewpoint - The company aims to expand its investment scale, diversify investment risks, accelerate investment pace, and improve investment efficiency through the establishment of the Guangzhou Liwan Pharmaceutical Venture Capital Fund [1][2] Group 1: Investment Details - The company’s board approved the subscription of limited partnership shares in the Guangzhou Liwan Pharmaceutical Venture Capital Fund, which will be established in collaboration with several partners [1] - The total fundraising target for the Guangzhou Liwan Fund is 300 million yuan, with the company contributing 99.5 million yuan, representing 33.17% of the fund [1] Group 2: Strategic Implications - This investment aligns with the strategic direction of the company’s second phase fund, enhancing its presence in innovative pharmaceuticals, modern traditional Chinese medicine, and high-end medical devices [2] - The approach of "investing early, investing small, and investing in the future" aims to engage with quality enterprises at their inception, fostering potential companies and accelerating technological upgrades and value chain extensions [2]